Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Revenue (2019 - 2025)

Historic Revenue for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to $12.5 million.

  • Avidity Biosciences' Revenue rose 43403.25% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 10626.67%. This contributed to the annual value of $10.9 million for FY2024, which is 1398.54% up from last year.
  • Avidity Biosciences' Revenue amounted to $12.5 million in Q3 2025, which was up 43403.25% from $3.8 million recorded in Q2 2025.
  • Over the past 5 years, Avidity Biosciences' Revenue peaked at $12.5 million during Q3 2025, and registered a low of $1.6 million during Q1 2025.
  • For the 5-year period, Avidity Biosciences' Revenue averaged around $3.0 million, with its median value being $2.3 million (2024).
  • Over the last 5 years, Avidity Biosciences' Revenue had its largest YoY gain of 43403.25% in 2025, and its largest YoY loss of 5560.26% in 2025.
  • Quarter analysis of 5 years shows Avidity Biosciences' Revenue stood at $1.9 million in 2021, then surged by 49.51% to $2.8 million in 2022, then dropped by 20.8% to $2.2 million in 2023, then soared by 35.57% to $3.0 million in 2024, then skyrocketed by 319.61% to $12.5 million in 2025.
  • Its Revenue stands at $12.5 million for Q3 2025, versus $3.8 million for Q2 2025 and $1.6 million for Q1 2025.